These findings strongly suggest that the NLRP3 inflammasome activation in cochlear macrophages contributes to OHC loss in CSOM, and targeting the NLRP3 inflammasome can prevent this loss. The gene discussed is NLRP3; the disease is chronic purulent otitis media.